Skip to main content
SpringerLink
Log in

Does pioglitazone reduce carotid intima–media thickness in patients with type 2 diabetes mellitus?

  • Practice Point
  • Published:

From Nature Clinical Practice Endocrinology & Metabolism

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Fonseca V et al. (2004) Non-traditional risk factors for cardiovascular disease in diabetes. Endocr Rev 25: 153–175

    Article  CAS  Google Scholar 

  2. Blaschke F et al. (2006) Peroxisome proliferator-activated receptor gamma agonists: their role as vasoprotective agents in diabetes. Endocrinol Metab Clin North Am 35: 561–574

    Article  CAS  Google Scholar 

  3. Dormandy JA et al. (2005) Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet 366: 1279–1289

    Article  CAS  Google Scholar 

  4. DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators (2006) Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet 368: 1096–1105

Download references

Acknowledgements

The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Section of Diabetes, Endocrinology and Metabolism, 983020 University of Nebraska Medical Center, Omaha, NE 68198-3020, USA cdesouza@unmc.edu

Authors and Affiliations

  1. C Desouza is an Assistant Professor in the Section of Diabetes, Endocrinology and Metabolism, University of Nebraska Medical Center, Omaha, NE, USA.,

    Cyrus Desouza

Authors
  1. Cyrus Desouza
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author has received research materials from Takeda.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Desouza, C. Does pioglitazone reduce carotid intima–media thickness in patients with type 2 diabetes mellitus?. Nat Rev Endocrinol 3, 394–395 (2007). https://doi.org/10.1038/ncpendmet0482

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet0482

  • Springer Nature Limited

Search

Navigation